| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/28/1999 | US5958783 Metal complexes with a charged linker |
| 09/28/1999 | US5958782 Cation-sensing composite structure and compounds for use therein |
| 09/28/1999 | US5958781 Absorbance spectrophotometry by diluting blood, mixing with lysis reagent, measuring optical density of stable and rapidly formed chromogen as indicator of hemoglobin concentration, and measuring leukocyte populations |
| 09/28/1999 | US5958780 Method for marking and identifying liquids |
| 09/28/1999 | US5958777 For continuously measuring amount of carbon dioxide and carbon monoxide contained in the effluent resulting from heating of the sample |
| 09/28/1999 | US5958776 Method for classifying and counting immature leukocytes |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/28/1999 | US5958738 Procedure for subtractive hybridization and difference analysis |
| 09/28/1999 | US5958736 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 09/28/1999 | US5958732 Anticoagulants in snake venom |
| 09/28/1999 | US5958730 Isolated nucleic acid compounds encoding ftsy, vectors and transformed host cells for expressing the encoded protein, which can be used for identifying compounds that bind or inhibit the protein when screening for novel antibiotics |
| 09/28/1999 | US5958723 DNA encoding prostaglandin receptor DP |
| 09/28/1999 | US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 09/28/1999 | US5958718 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 09/28/1999 | US5958717 Contacting sample with homocysteine converting enzyme; without chromatographic separation, assessing non-labeled homocysteine conversion products |
| 09/28/1999 | US5958716 Blood factor assay |
| 09/28/1999 | US5958715 Method for quantitative measurement of an enzyme linked immunosorbent assay |
| 09/28/1999 | US5958714 Qualitative and quantitative analysis with matrices, membranes and reaction vessels |
| 09/28/1999 | US5958713 Method of detecting biologically active substances by using green fluorescent protein |
| 09/28/1999 | US5958712 Identifying altered t cell receptor ligand comprising major histocompatible complex and peptide that inhibits t cell effector response |
| 09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
| 09/28/1999 | US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and |
| 09/28/1999 | US5958707 Human interleukin-4 antagonist/agonist screens |
| 09/28/1999 | US5958706 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof |
| 09/28/1999 | US5958705 Cytoplasmic modulators of integrin regulation/signaling |
| 09/28/1999 | US5958704 Sensing system for specific substance and molecule detection |
| 09/28/1999 | US5958703 Screening complexes of test compound, a tag recording at least one step in the synthesis of the compound, and a tether sensitive to produced reporter molecule; separating complexes with modified tethers; decoding tag |
| 09/28/1999 | US5958702 Receptor-assisted combinatorial chemistry |
| 09/28/1999 | US5958700 Hybridizing oligonucleotide having base-paired secondary structure and linked quenched fluorescent dyes, synthesizing complementary strand by primer extension causing linearization of structure and changing fluorescence |
| 09/28/1999 | US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer |
| 09/28/1999 | US5958697 Isolated nucleic acids encoding CYP7 promoter-binding factors |
| 09/28/1999 | US5958692 Detection of mutation by resolvase cleavage |
| 09/28/1999 | US5958691 High affinity nucleic acid ligands containing modified nucleotides |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | US5958673 New class of solvent matrix sensitive dyes which possess reactive linkers for attachment to nucleic acids, carbohydrates and peptides; operate in the visible and ultraviolet spectrum; photostability |
| 09/28/1999 | US5958424 Recombinant chicken anemia virus particle |
| 09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
| 09/28/1999 | US5958407 Ileus treatment method |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | US5958371 Site specific binding system, nuclear imaging compositions and methods |
| 09/28/1999 | US5958340 Sensor having a thick film of sintered copper, barium, titanium and cerium oxides acts as a conductivity sensor which responds to a change in concentration of carbon dioxide by increasing or decreasing resistance; inexpensive, accurate |
| 09/28/1999 | US5958339 Comprising support, reagent matrix having porous material on support, light absorber or reflector and read area for absorbing and blocking interferents; detection of trace quantities of biological compounds |
| 09/28/1999 | US5958300 Amino glycol buffer, amino acid, nonionic detergent, and salt; preserves the immunoreactivity of a target antigen in patient samples, allowing their detection in acidic or formalin containing medium |
| 09/28/1999 | US5958299 Explosive simulants for testing explosive detection systems |
| 09/28/1999 | US5958250 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 09/28/1999 | US5958202 Capillary electrophoresis enzyme immunoassay |
| 09/28/1999 | US5958200 Electrochemical gas sensor |
| 09/28/1999 | US5958082 Garments with considerable variation in abrasion level |
| 09/28/1999 | US5956994 Test apparatus for linear test material such as yarn or the like |
| 09/28/1999 | CA2173350C Apparatus for testing a shear thickening plugging fluid |
| 09/28/1999 | CA2088354C Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 09/28/1999 | CA2072095C Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 09/24/1999 | CA2249660A1 Novel compounds |
| 09/23/1999 | WO1999047963A1 Confocal microscopy imaging system |
| 09/23/1999 | WO1999047934A2 Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins) |
| 09/23/1999 | WO1999047933A1 Flow cytometry with non-fluorescent microbeads |
| 09/23/1999 | WO1999047932A2 Diagnosis of spongiform or de-myelinating disease |
| 09/23/1999 | WO1999047931A1 Method for detecting microbes from an enrichment culture |
| 09/23/1999 | WO1999047930A1 Immunoassay device and method |
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047928A2 Systems and methods for rapid blot screening |
| 09/23/1999 | WO1999047927A1 An equine neospora isolate and its uses |
| 09/23/1999 | WO1999047926A2 Materials and methods relating to identifying inositolphosphoglycan mimetics |
| 09/23/1999 | WO1999047925A2 Methods and compositions for diagnosis of rheumatoid arthritis |
| 09/23/1999 | WO1999047924A1 Detection of apoptotic products |
| 09/23/1999 | WO1999047923A2 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 09/23/1999 | WO1999047922A2 Vascularized perfused microtissue/micro-organ arrays |
| 09/23/1999 | WO1999047921A1 CO-EXPRESSION OF Gia PROTEIN AND Gi PROTEIN COUPLED RECEPTOR TO ENHANCE SIGNAL TRANSDUCTION RESPONSES |
| 09/23/1999 | WO1999047920A1 New assays for screening for substances and compounds influencing apoptosis |
| 09/23/1999 | WO1999047919A1 Device for determining the lubricating power of fluids |
| 09/23/1999 | WO1999047918A1 Lifetime-based sensing of sodium and potassium |
| 09/23/1999 | WO1999047917A1 In situ copper (i) determination |
| 09/23/1999 | WO1999047915A1 Method for zero point stabilization of an exhaust-gas sensor and an arrangement for carrying out said method |
| 09/23/1999 | WO1999047907A1 Device for the determination of blood clotting by capacitance or resistance |
| 09/23/1999 | WO1999047906A1 Electronic apparatus for dispensing precise small quantities of fluid |
| 09/23/1999 | WO1999047905A2 Handheld sensing apparatus |
| 09/23/1999 | WO1999047705A1 Detection method |
| 09/23/1999 | WO1999047699A1 Screening for blood coagulation defects using metal ions |
| 09/23/1999 | WO1999047696A2 Assays for detecting substances with an anti-hiv action |
| 09/23/1999 | WO1999047677A2 Polypeptides homologous to vegf and bmp1 |
| 09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | WO1999047670A1 Mammalian sodium channel proteins |
| 09/23/1999 | WO1999047662A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 09/23/1999 | WO1999047643A1 Selection subtraction approach to gene identification |
| 09/23/1999 | WO1999047639A2 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047563A2 Ribonucleotide polypeptides containing metal |
| 09/23/1999 | WO1999047562A1 Nephrin gene and protein |
| 09/23/1999 | WO1999047553A2 Bacterial yeal family members as targets for antimicrobial drug design |
| 09/23/1999 | WO1999047540A1 95 human secreted proteins |
| 09/23/1999 | WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 09/23/1999 | WO1999047527A1 USE OF AMINOPHOSPHONATES AS31P NMR pH INDICATORS |
| 09/23/1999 | WO1999047261A1 Method and apparatus for measuring proteins |
| 09/23/1999 | WO1999047178A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
| 09/23/1999 | WO1999047167A1 Double mutant enterotoxin for use as an adjuvant |
| 09/23/1999 | WO1999047164A1 Use of mutant enterotoxin with excess b-subunit as an adjuvant |
| 09/23/1999 | WO1999047147A1 nrdG |